Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03469570 · ClinicalTrials.gov registry record · NA
Assisted Fluid Management IDE Study
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT03469570 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 330 participants.
The verdict
NCT03469570, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the performance of the Acumen™ Assisted Fluid Management (AFM) Feature in its ability to predict a subject's fluid responsiveness.
Interventions
- DEVICE EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2018-04-19 |
| Est. Completion | 2019-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03469570
The ClinicalTrials.gov registry entry for NCT03469570 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature is the first listed.
NCT03469570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03469570 about?
NCT03469570 is a clinical study titled "Assisted Fluid Management IDE Study". The primary objective of this study is to evaluate the performance of the Acumen™ Assisted Fluid Management (AFM) Feature in its ability to predict a subject's fluid responsiveness.
What is the current status of trial NCT03469570?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2018-04-19. Estimated completion is 2019-01-25.
What interventions are being tested in trial NCT03469570?
The interventions under investigation include: EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature (DEVICE).
Who is sponsoring clinical trial NCT03469570?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.